These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28845591)

  • 61. Cancer-induced muscle atrophy is determined by intrinsic muscle oxidative capacity.
    Alves CRR; Eichelberger EJ; das Neves W; Ribeiro MAC; Bechara LRG; Voltarelli VA; de Almeida NR; Hagen L; Sharma A; Ferreira JCB; Swoboda KJ; Slupphaug G; Brum PC
    FASEB J; 2021 Jul; 35(7):e21714. PubMed ID: 34118107
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
    Argilés JM; Busquets S; Felipe A; López-Soriano FJ
    Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.
    White JP; Puppa MJ; Sato S; Gao S; Price RL; Baynes JW; Kostek MC; Matesic LE; Carson JA
    Skelet Muscle; 2012 Jul; 2():14. PubMed ID: 22769563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
    Dolly A; Dumas JF; Servais S
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1413-1428. PubMed ID: 33053604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
    Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
    Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
    BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass.
    Liu H; Zang P; Lee II; Anderson B; Christiani A; Strait-Bodey L; Breckheimer BA; Storie M; Tewnion A; Krumm K; Li T; Irwin B; Garcia JM
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1280-1295. PubMed ID: 34264027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy.
    Chen JM; Yang TT; Cheng TS; Hsiao TF; Chang PM; Leu JY; Wang FS; Hsu SL; Huang CF; Lai JM
    J Ethnopharmacol; 2019 Apr; 233():47-55. PubMed ID: 30590199
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of skeletal muscle fibrosis in a rodent model of cancer cachexia.
    Washington TA; Schrems ER; Haynie WS; Rosa-Caldwell ME; Brown JL; Saling L; Lim S; Perry RA; Brown LA; Lee DE; Greene NP
    Cell Biochem Funct; 2023 Jun; 41(4):478-489. PubMed ID: 37150891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Muscle wasting in cancer: the role of mitochondria.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Platelet status in cancer cachexia progression in Apc
    Cunningham P; Unger CA; Patton EA; Aiken A; Browne A; James E; Aladhami AK; Hope Rd MC; VanderVeen BN; Cardaci TD; Murphy EA; Enos RT; Velázquez KT
    Front Immunol; 2023; 14():1253587. PubMed ID: 37701438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations.
    Pin F; Busquets S; Toledo M; Camperi A; Lopez-Soriano FJ; Costelli P; Argilés JM; Penna F
    Oncotarget; 2015 Dec; 6(41):43202-15. PubMed ID: 26636649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle.
    Wei L; Wang R; Wazir J; Lin K; Song S; Li L; Pu W; Zhao C; Wang Y; Su Z; Wang H
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
    Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Muscle p62 stimulates the expression of antioxidant proteins alleviating cancer cachexia.
    Yamada M; Warabi E; Oishi H; Lira VA; Okutsu M
    FASEB J; 2023 Sep; 37(9):e23156. PubMed ID: 37624620
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cancer-induced Cardiac Atrophy Adversely Affects Myocardial Redox State and Mitochondrial Oxidative Characteristics.
    Lee DE; Brown JL; Rosa-Caldwell ME; Perry RA; Brown LA; Haynie WS; Washington TA; Wiggs MP; Rajaram N; Greene NP
    JCSM Rapid Commun; 2021; 4(1):3-15. PubMed ID: 33693448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.